Eurolung risk score is associated with long-term survival after curative resection for lung cancer
- PMID: 32948299
- PMCID: PMC7444606
- DOI: 10.1016/j.jtcvs.2020.06.151
Eurolung risk score is associated with long-term survival after curative resection for lung cancer
Abstract
Objective: The study objective was to verify whether the Eurolung score was associated with long-term prognosis after lung cancer resection.
Methods: A total of 1359 consecutive patients undergoing anatomic lung resection (1136 lobectomies, 103 pneumonectomies, 120 segmentectomies) (2014-2018) were analyzed. The parsimonious aggregate Eurolung2 score was calculated for each patient. Median follow-up was 802 days. Survival distribution was estimated by the Kaplan-Meier method. Cox proportional hazard regression and competing risk regression analyses were used to assess the independent association of Eurolung with overall and disease-specific survival.
Results: Patients were grouped into 4 classes according to their Eurolung scores (A 0-2.5, B 3-5, C 5.5-6.5, D 7-11.5). Most patients were in class A (52%) and B (33%), 8% were in class C, and 7% were in class D. Five-year overall survival decreased across the categories (A: 75%; B: 52%; C: 29%; D: 27%, log rank P < .0001). The score stratified the 3-year overall survival in patients with pT1 (P < .0001) or pT>1 (P < .0001). In addition, the different classes were associated with incremental risk of long-term overall mortality in patients with pN0 (P < .0001) and positive nodes (P = .0005). Cox proportional hazard regression and competing regression analyses showed that Eurolung aggregate score remained significantly associated with overall (hazard ratio, 1.19; P < .0001) and disease-specific survival after adjusting for pT and pN stage (hazard ratio, 1.09; P = .005).
Conclusions: Eurolung aggregate score was associated with long-term survival after curative resection for cancer. This information may be valuable to inform the shared decision-making process and the multidisciplinary team discussion assisting in the selection of the most appropriate curative treatment in high-risk patients.
Keywords: Eurolung; lung cancer; risk model; risk stratification; surgery; survival.
Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Commentary: Eurolung score as a predictor of long-term survival: It is not all about the tumor.J Thorac Cardiovasc Surg. 2021 Mar;161(3):788-789. doi: 10.1016/j.jtcvs.2020.07.006. Epub 2020 Jul 11. J Thorac Cardiovasc Surg. 2021. PMID: 32800373 Free PMC article. No abstract available.
-
Commentary: Patient frailty also drives long-term outcomes after R0 resection for lung cancer.J Thorac Cardiovasc Surg. 2021 Mar;161(3):787-788. doi: 10.1016/j.jtcvs.2020.06.115. Epub 2020 Jul 14. J Thorac Cardiovasc Surg. 2021. PMID: 32868059 Free PMC article. No abstract available.
References
-
- Brunelli A., Cicconi S., Decaluwe H., Szanto Z., Falcoz P.E. Parsimonious Eurolung risk models to predict cardiopulmonary morbidity and mortality following anatomic lung resections: an updated analysis from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg. 2020;57:455–461. - PubMed
-
- Brunelli A., Pompili C., Berardi R., Mazzanti P., Onofri A., Salati M., et al. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer. Ann Thorac Surg. 2012;93:1796–1800. - PubMed
-
- Brunelli A., Pompili C., Salati M., Refai M., Berardi R., Mazzanti P., et al. Preoperative maximum oxygen consumption is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer. Ann Thorac Surg. 2014;98:238–242. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
